{"id":511963,"date":"2020-10-15T17:22:01","date_gmt":"2020-10-15T17:22:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=511963"},"modified":"2020-10-15T17:22:01","modified_gmt":"2020-10-15T17:22:01","slug":"global-cold-and-cough-preparations-market-value-expected-to-reach-14-billion-by-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-cold-and-cough-preparations-market-value-expected-to-reach-14-billion-by-2023_511963.html","title":{"rendered":"Global Cold And Cough Preparations Market Value Expected To Reach $14 Billion By 2023"},"content":{"rendered":"
\"Global<\/a><\/p>\n
\n
Cough And Cold Preparations Global Market Report 2020-30: Covid 19 Implications And Growth\n<\/div>\n<\/div>\n<\/div>\n
AstraZeneca Is One Of The Largest Players In The Cold and Cough Preparations Market, According To The Business Research Company\u2019s Cough And Cold Preparations Global Market Report 2020-30: Covid 19 Implications And Growth<\/p>\n<\/div>\n

(Companies Covered: AstraZeneca, Bayer, Blackmores Limited, Dabur, GlaxoSmithKline, Himalaya Global Holdings, Hyland`s, Johnson & Johnson, Novartis, Perrigo Company, Pfizer, Prestige Brands)<\/em><\/p>\n

The global cough and cold preparations market is expected to grow from $13.1 billion in 2019 to $15.4 billion in 2020 at a compound annual growth rate of 17.7%. The respiratory drugs market witnessed significant growth mainly due to the COVID-19 outbreak. The fact that Covid-19 is essentially a respiratory ailment has boosted the market growth. The market is then expected to decline at a compound annual growth rate of -2.2% from 2021 and reach $14 billion in 2023.<\/p>\n

Read More On The Global Cold and Cough Preparations Market Report At –
<\/strong>https:\/\/www.thebusinessresearchcompany.com\/report\/cough-and-cold-preparations-global-market-report<\/a><\/p>\n

<\/strong>The cold and cough preparations market consists of sales of drugs for cold and cough. The drugs for the treatment of cold and cough acts on the receptors to which the virus causing the infection gets attached to, by antagonizing the action of the receptors and killing the viral infection, thereby reducing congestion by lysing the mucus and dilating the bronchioles constricted by the mucus deposition. <\/p>\n

Global Cold and Cough Preparations Market Segmentation –
<\/strong>1) By Drug Type:<\/strong> Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others.
2) By Dosage Type:<\/strong> Oral Syrups, Tablets\/Pills, Nasal Drops, Lozenges, Others.
<\/strong>3) By Distribution Channel:<\/strong> Hospital Pharmacies, Retail Pharmacies, Drug Stores. <\/p>\n

Global Cold and Cough Preparations Market Driver –
<\/strong>The cold and flu season is the major driver of sales for products related to prevention and treatment of cold and cough. Cold weather is not directly associated with common cold, but the virus which causes common cold, called rhinovirus, is responsible for all cold related illnesses. Once the virus is inhaled, it attaches to the cells in nasal passages<\/p>\n

Request For A Sample Of The Global Cold and Cough Preparations Market Report At –
<\/strong>https:\/\/www.thebusinessresearchcompany.com\/sample.aspx?id=2585&type=smp<\/a><\/p>\n

Few Points From The Global Cold and Cough Preparations Market TOC
<\/strong>1. Executive Summary
2. Cold and Cough Preparations Market Characteristics
3. Cold and Cough Preparations Market Size And Growth
3.1. Global Cold and Cough Preparations Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Cold and Cough Preparations Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
4. Cold and Cough Preparations Market Segmentation
4.1. Global Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billiones.
5. Cold and Cough Preparations Market Regional And Country Analysis
5.1. Global Cold and Cough Preparations Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Cold and Cough Preparations Market 
6.1. Asia-Pacific Cold and Cough Preparations Market Overview 
6.2. Asia-Pacific Cold and Cough Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion<\/p>\n

<\/strong>Interested to know more about The Business Research Company? <\/strong> <\/strong><\/p>\n

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> The Business Research Company<\/a>
Contact Person:<\/strong> Oliver Guirdham
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +44 20 7193 0708
Address:<\/strong>
City:<\/strong> London
State:<\/strong> Greater London
Country:<\/strong> United Kingdom
Website:<\/strong> https:\/\/www.thebusinessresearchcompany.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Cough And Cold Preparations Global Market Report 2020-30: Covid 19 Implications And Growth AstraZeneca Is One Of The Largest Players In The Cold and Cough Preparations Market, According To The Business Research Company\u2019s Cough And Cold Preparations Global Market Report … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-511963","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/511963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=511963"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/511963\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=511963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=511963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=511963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}